PBYI
NASDAQ · Biotechnology
Puma Biotechnology Inc
$6.19
-0.06 (-0.96%)
Financial Highlights (FY 2026)
Revenue
218.79M
Net Income
28.75M
Gross Margin
72.1%
Profit Margin
13.1%
Rev Growth
-3.1%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 72.1% | 72.1% | 67.8% | 67.8% |
| Operating Margin | 13.4% | 12.1% | 23.2% | 29.3% |
| Profit Margin | 13.1% | 12.5% | 18.7% | 21.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 218.79M | 225.76M | 42.11M | 46.96M |
| Gross Profit | 157.66M | 162.68M | 28.56M | 31.85M |
| Operating Income | 29.40M | 27.31M | 9.75M | 13.74M |
| Net Income | 28.75M | 26.70M | 7.89M | 10.24M |
| Gross Margin | 72.1% | 72.1% | 67.8% | 67.8% |
| Operating Margin | 13.4% | 12.1% | 23.2% | 29.3% |
| Profit Margin | 13.1% | 12.5% | 18.7% | 21.8% |
| Rev Growth | -3.1% | -3.1% | +7.6% | -6.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 66.76M | 66.76M | 115.20M | 98.43M |
| Total Equity | 91.72M | 91.72M | 249.14M | 242.47M |
| D/E Ratio | 0.73 | 0.73 | 0.46 | 0.41 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 41.15M | 40.34M | 13.15M | 15.14M |
| Free Cash Flow | — | — | 4.76M | 6.11M |